ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business Gross Profit Increases to $8.9 Million With Net Income of $1.1 Million or $0.07 Per Share ...

ProPhase Labs Announces Pricing of Public Offering of Common Stock GARDEN CITY, NY, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of an underwritten public...

ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York Company Expands to Meet Anticipated Demand for Increased Molecular Testing From New Business Opportunities – Aiming For Capacity to Process 50,000 Tests per Day Doylestown, PA, Dec. 08, 2020 (GLOBE...

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020 DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...

ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing DOYLESTOWN, Pennsylvania, Oct. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today a definitive agreement to...